Moody's: Global drugmakers to bounce back this year

04/26/2013 | PharmaTimes (U.K.)

The global pharmaceutical market is poised to return to earnings growth this year as the patent cliff eases, according to a report from Moody's. Merger and acquisition deals will likely increase, but transactions will be in the small to midsize range. In the U.S., the regulatory pathway for biosimilars will get clearer, with potential regulatory applications this year, according to the report.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC